Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001493152-26-025474

Chief Financial Officer bought 14,235 shares at $1.41 ($20,000)

From the SEC's structured data for this filing

Trades in this filing

Byam Rebecca · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-22 Purchase : show line 1 in the form +14,235 $1.41 $20,000 57,245 D
Open-market purchases · 14,235 sh · avg $1.41 · $20,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-22 Purchase : show line 2 in the form Common Stock Purchase Warrant +14,235 18,466 D
Loading xslF345X06/ownership.xml…